These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 32724177)
1. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease. Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177 [TBL] [Abstract][Full Text] [Related]
2. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats. Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101 [TBL] [Abstract][Full Text] [Related]
3. GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease. Schneider JS; Singh G; Williams CK; Singh V Mol Cell Neurosci; 2022 May; 120():103729. PubMed ID: 35447351 [TBL] [Abstract][Full Text] [Related]
4. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease. Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034 [TBL] [Abstract][Full Text] [Related]
5. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation. Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554 [TBL] [Abstract][Full Text] [Related]
6. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease. Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074 [TBL] [Abstract][Full Text] [Related]
7. GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease. Schneider JS; Aras R; Williams CK; Koprich JB; Brotchie JM; Singh V Sci Rep; 2019 Jun; 9(1):8362. PubMed ID: 31182727 [TBL] [Abstract][Full Text] [Related]
8. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model. Seo MH; Yeo S Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells. Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways. Park JS; Choe K; Lee HJ; Park TJ; Kim MO J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205 [TBL] [Abstract][Full Text] [Related]
11. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models. Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3. Guo YJ; Dong SY; Cui XX; Feng Y; Liu T; Yin M; Kuo SH; Tan EK; Zhao WJ; Wu YC Mol Nutr Food Res; 2016 Oct; 60(10):2161-2175. PubMed ID: 27296520 [TBL] [Abstract][Full Text] [Related]
13. Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse. Itokazu Y; Fuchigami T; Morgan JC; Yu RK Mol Ther; 2021 Oct; 29(10):3059-3071. PubMed ID: 34111562 [TBL] [Abstract][Full Text] [Related]
14. Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against Aβ1-42-Induced Neurotoxicity and Cognitive Deficits. Dai R; Zhang S; Duan W; Wei R; Chen H; Cai W; Yang L; Wang Q Neurochem Res; 2017 Aug; 42(8):2417-2426. PubMed ID: 28497346 [TBL] [Abstract][Full Text] [Related]
15. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy. Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399 [TBL] [Abstract][Full Text] [Related]
16. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein. Lan DM; Liu FT; Zhao J; Chen Y; Wu JJ; Ding ZT; Yue ZY; Ren HM; Jiang YP; Wang J Neurochem Res; 2012 Sep; 37(9):2025-32. PubMed ID: 22707286 [TBL] [Abstract][Full Text] [Related]
17. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism. Schneider JS; Yuwiler A Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945 [TBL] [Abstract][Full Text] [Related]
18. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP Wu KC; Liou HH; Lee CY; Lin CJ Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389 [TBL] [Abstract][Full Text] [Related]
20. Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model Mice. Fuchigami T; Itokazu Y; Morgan JC; Yu RK Mol Neurobiol; 2023 Jun; 60(6):3329-3344. PubMed ID: 36849668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]